cyclosporine has been researched along with Melanoma in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (25.64) | 18.2507 |
| 2000's | 14 (35.90) | 29.6817 |
| 2010's | 13 (33.33) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Cerqueira, F; Florêncio, MH; Justino, F; Marcelo-Curto, MJ; Moiteiro, C; Nascimento, MS; Pedro, M; Pinto, MM; Tavares, R | 1 |
| Arancia, G; Condello, M; Corinti, S; Cosentino, D; Di Felice, G; Gallo, FR; Meschini, S; Multari, G | 1 |
| Gajewski, TF; Luke, JJ; Olson, DJ; Rajagopal, P; Tjota, MY; Venkataraman, G | 1 |
| Arance, A; Ordás, I; Pesántez, D; Seguí, E; Viladot, M | 1 |
| Ascha, M; Ascha, MS; Bordeaux, JS; Tanenbaum, J | 1 |
| Arndt, S; Bosserhoff, AK; Fischer, MJM; Gebhardt, L; Karrer, S; Schneider, C; Zimmermann, JL | 1 |
| Carranza, A; Coveñas, R; González-Ortega, A; Muñoz, M; Ramiro-Fuentes, S; Salinas-Martín, MV; Sánchez-Vaderrábanos, E | 1 |
| Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB | 1 |
| Akhavanpoor, M; Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Erbel, C; Frankenstein, L; Gleissner, CA; Helmschrott, M; Katus, HA; Klein, B; Rivinius, R; Ruhparwar, A; Schmack, B; Thomas, D | 1 |
| Dotor, A; González-Herrada, C; Lapresta, A | 1 |
| Gergely, P; Hajdú, T; Juhász, T; Katona, É; Kókai, E; Rácz, K; Somogyi, CS; Szász, C; Zákány, R | 1 |
| Diem, S; Larkin, J; Spain, L | 1 |
| Fodor, J; Gergely, P; Juhász, T; Matta, C; Molnár, Z; Nagy, G; Szíjgyártó, Z; Veress, G; Zákány, R | 1 |
| Allshire, A; Anoopkumar-Dukie, S; Conere, T; Sisk, GD | 1 |
| Cervinka, M; Rudolf, E; Rudolf, K | 1 |
| Eagle, RC; Edward, DP; Fontanilla, FA; Goldstein, DA; Tessler, HH; Wong, M | 1 |
| Martin, L | 1 |
| Arcese, A; Camplone, G; Carlesimo, M; Di Russo, PP; Gamba, A; La Pietra, M; Mari, E; Orsini, D | 1 |
| Berger, W; Bilban, M; Bracher, A; Heinz, M; Knöfler, M; Loewe, R; Niederleithner, H; Pehamberger, H; Petzelbauer, P; Sonderegger, S; Tauber, S | 1 |
| Anichini, A; Baldassari, P; Bersani, I; Dal Col, J; Dolcetti, R; Molla, A; Mortarini, R; Perotti, V; Tassi, E; Vegetti, C | 1 |
| Blanco, G; Diebold, Y; Domingo, E; Fernández, N; Lopez, R; Mayo-Iscar, A; Morilla-Grasa, A; Ordoñez, JL; Rabano, G; Saornil, MA | 1 |
| Andrassy, J; Geissler, EK; Graeb, C; Guba, M; Jauch, KW; Koehl, GE; Kroemer, A; Richter, S; Scherer, MN; Schlitt, HJ; Steinbauer, M | 1 |
| Feun, L; Hurley, J; Marini, A; Mazumder, A; Moffat, F; Savaraj, N | 1 |
| Antin, J; Granter, S; Hodi, FS | 1 |
| Birkholz, K; Dörrie, J; Ferrone, S; Fey, GH; Kämpgen, E; Kellner, C; Kügler, M; Nettelbeck, DM; Peipp, M; Schaft, N; Schuler-Thurner, B; Schwemmlein, M; Schwenkert, M | 1 |
| Fenton, RG; Peltz, G; Taub, DD; Turcovski-Corrales, SM | 1 |
| Kautzky, F; Köhler, LD; Vogt, HJ | 1 |
| Bellamy, J; Benoit, G; Blanchet, P; Charpentier, B; Hiesse, C; Kriaa, F; Larue, JR | 1 |
| de Waard-Siebinga, I; de Wolff-Rouendaal, D; Jager, M; van Delft, JL | 1 |
| Gragoudas, ES; Hu, LK; Huh, K; Young, LH | 1 |
| Kan-Mitchel, J; Liggett, PE; Lo, G; Pascal, SG; Pince, KJ; Rao, NA | 1 |
| Ackerman, S; Ernstoff, MS; Jones, H; Kirkwood, JM; Saria, EA; Schwartz, R; Selvaggi, K; Vlock, DR; Wedel, N | 1 |
| Czyz, W; Sobczak-Radwan, K; Szepietowski, J; Szepietowski, T; Wasik, F; Włodarczyk, M | 1 |
| Arancia, G; Calcabrini, A; Cianfriglia, M; Del Bufalo, D; Meschini, S; Molinari, A; Stringaro, A | 1 |
| Dong, H; Hirpara, JL; Kini, RM; Loh, KW; Pervaiz, S; Seyed, MA | 1 |
| Bacin, F; Bonicel, P; Kemeny, JL; Madelmont, JC; Michelot, J; Moins, N; Morvan, D; Papon, J | 1 |
| Bradford, B; Enomoto, N; Ikejema, K; Rose, ML; Rusyn, I; Schemmer, P; Seabra, V; Stacklewitz, RF; Thurman, RG; Wheeler, MD; Yin, M; Zhong, Z | 1 |
| Grubb, DR; Johnson, KL; Lawen, A; Ly, JD; Vaillant, F | 1 |
| Amenábar, JJ; Gaínza, FJ; Gómez-Ullate, P; Lampreabe, I; Urbizu, JM; Zárraga, S | 1 |
5 review(s) available for cyclosporine and Melanoma
| Article | Year |
|---|---|
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha | 2014 |
Management of toxicities of immune checkpoint inhibitors.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Colitis; CTLA-4 Antigen; Cyclosporine; Diarrhea; Drug Eruptions; Humans; Immunosuppressive Agents; Infliximab; Ipilimumab; Kidney Neoplasms; Lung Neoplasms; Melanoma; Mycophenolic Acid; Neoplasms; Nivolumab; Pituitary Diseases; Programmed Cell Death 1 Receptor; Skin Neoplasms; Tacrolimus; Thyroiditis | 2016 |
[What's new in dermatological treatments?].
Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab | 2010 |
Glycine: a new anti-inflammatory immunonutrient.
Topics: Alcohols; Animals; Anti-Inflammatory Agents; Calcium Channels, L-Type; Chloride Channels; Cyclosporine; Free Radicals; Glycine; Hepatitis, Alcoholic; Humans; Hypoxia; Inflammation; Kupffer Cells; Leukocytes; Melanoma; Reperfusion Injury; Shock, Septic; Taurine | 1999 |
[Presentation of cancers in recipients of a solid-organ transplant].
Topics: Carcinogens; Cell Transformation, Neoplastic; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Melanoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Postoperative Complications; Prevalence; Recurrence; Risk; Sarcoma, Kaposi; Skin Neoplasms; Transplantation; Tumor Virus Infections; Ultraviolet Rays | 2001 |
2 trial(s) available for cyclosporine and Melanoma
| Article | Year |
|---|---|
Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclosporine; Dacarbazine; Female; Humans; Immunosuppressive Agents; Interferon-alpha; Interleukin-2; Male; Melanoma; Skin Neoplasms; Tamoxifen; Treatment Outcome | 2005 |
Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma.
Topics: Aged; Animals; Antibodies, Monoclonal; Antibody Formation; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunotoxins; Male; Melanoma; Mice; Middle Aged; Ricin | 1993 |
32 other study(ies) available for cyclosporine and Melanoma
| Article | Year |
|---|---|
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Lung Neoplasms; Lymphocytes; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Oxidation-Reduction; Portugal; Quercus; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2001 |
Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.
Topics: Alkaloids; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fibroblasts; Fluorescent Antibody Technique; Humans; Ibogaine; Melanoma; Molecular Structure; Osteosarcoma | 2014 |
A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Humans; Ipilimumab; Melanoma; Nivolumab; Prognosis | 2020 |
Successful management of refractory immune-mediated enterocolitis with cyclosporine.
Topics: Adult; Antineoplastic Agents, Immunological; Biopsy; Colon; Colonoscopy; Cyclosporine; Drug Resistance; Enterocolitis; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Melanoma; Methylprednisolone; Programmed Cell Death 1 Receptor; Skin Neoplasms; Treatment Outcome | 2020 |
Risk Factors for Melanoma in Renal Transplant Recipients.
Topics: Adult; Age Factors; Aged; Cohort Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Male; Melanoma; Middle Aged; Registries; Risk Factors; Sirolimus; Skin Neoplasms; Time Factors; Tissue Donors; Transplant Recipients; United States | 2017 |
Cold atmospheric plasma causes a calcium influx in melanoma cells triggering CAP-induced senescence.
Topics: Aging; Calcium; Calcium Channels; Cell Line, Tumor; Chelating Agents; Cold Temperature; Cryotherapy; Cyclosporine; Endoplasmic Reticulum; Humans; Melanoma; Mitochondria; Plasma Gases; Ryanodine | 2018 |
Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclosporine; Drug Screening Assays, Antitumor; Female; Gene Expression; HEK293 Cells; Humans; Inhibitory Concentration 50; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Uveal Neoplasms; Young Adult | 2014 |
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Melanoma; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasms; Risk Factors; Skin Neoplasms; Survival Analysis; Tacrolimus | 2015 |
Toxic epidermal necrolysis induced by vemurafenib.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Drug Substitution; Humans; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Stevens-Johnson Syndrome; Sulfonamides; Vemurafenib | 2015 |
PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines.
Topics: Calcineurin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclosporine; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Hyaluronan Receptors; Hyaluronan Synthases; Hyaluronic Acid; MAP Kinase Signaling System; Melanoma; Phosphoproteins; Phosphorylation; Protein Phosphatase 2 | 2016 |
Inhibition of calcineurin by cyclosporine A exerts multiple effects on human melanoma cell lines HT168 and WM35.
Topics: Apoptosis; Calcineurin Inhibitors; Calcium; Calmodulin; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Cytosol; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Melanoma; Psoriasis; RNA, Messenger | 2009 |
Mitochondrial modulation of oxygen-dependent radiosensitivity in some human tumour cell lines.
Topics: Anti-Bacterial Agents; bcl-2-Associated X Protein; Bongkrekic Acid; Breast Neoplasms; Cell Line, Tumor; Cyclosporine; Female; Humans; Immunosuppressive Agents; Melanoma; Mitochondria; Oxidative Stress; Radiation Tolerance; Tacrolimus; Uterine Cervical Neoplasms | 2009 |
Cytotoxicity and mitochondrial apoptosis induced by etoposide in melanoma cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Apoptosis; Ataxia Telangiectasia Mutated Proteins; bcl-2-Associated X Protein; Benzothiazoles; Caspase 2; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Cycle Proteins; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Damage; DNA-Binding Proteins; Etoposide; Humans; Melanoma; Mitochondria; Neoplasm Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Superoxides; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2009 |
Juvenile xanthogranuloma masquerading as melanoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Child; Chlorambucil; Cyclosporine; Diagnosis, Differential; Drug Resistance; Humans; Immunosuppressive Agents; Male; Melanoma; Prednisone; Skin Neoplasms; Visual Acuity; Xanthogranuloma, Juvenile | 2009 |
Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Melanoma; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Skin Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Wnt1 is anti-lymphangiogenic in a melanoma mouse model.
Topics: Animals; Cyclosporine; Disease Models, Animal; Female; Humans; Lymphangiogenesis; Lymphatic Metastasis; Melanoma; Mice; Mice, Inbred C57BL; Mice, SCID; Skin Neoplasms; Tumor Cells, Cultured; Vascular Endothelial Growth Factor C; Wnt Signaling Pathway; Wnt1 Protein | 2012 |
NFATc2 is a potential therapeutic target in human melanoma.
Topics: Apoptosis; Calcineurin; Caspase 2; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Cysteine Endopeptidases; Down-Regulation; Enzyme Inhibitors; Humans; Inhibitor of Apoptosis Proteins; MAP Kinase Signaling System; Melanoma; NFATC Transcription Factors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2012 |
The need for continuous immunosuppression with cyclosporin A to maintain an experimental model of uveal melanoma.
Topics: Animals; Body Weight; Cyclosporine; Disease Models, Animal; Humans; Immunosuppressive Agents; Male; Melanoma; Mitosis; Neoplasms, Experimental; Rabbits; Time Factors; Tumor Cells, Cultured; Uvea; Uveal Neoplasms | 2002 |
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, SCID; Sirolimus; Skin Neoplasms; Transplantation, Homologous | 2004 |
Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report.
Topics: Anemia, Aplastic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Melanoma; Remission Induction; Sirolimus; Tacrolimus | 2005 |
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
Topics: ADP Ribose Transferases; Apoptosis; Bacterial Toxins; Cell Line, Tumor; Chondroitin Sulfate Proteoglycans; Cyclosporine; Cytotoxicity, Immunologic; Exotoxins; Humans; Immunosuppressive Agents; Immunotherapy; Immunotoxins; Melanoma; Pseudomonas aeruginosa Exotoxin A; Recombinant Fusion Proteins; Tumor Cells, Cultured; Virulence Factors | 2008 |
CD28:B7 interactions promote T cell adhesion.
Topics: Abatacept; Androstadienes; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; B7-1 Antigen; CD28 Antigens; Cell Adhesion; Cell Adhesion Molecules; CTLA-4 Antigen; Cyclosporine; Enzyme Inhibitors; Humans; Immunoconjugates; Immunosuppressive Agents; Integrins; Melanoma; T-Lymphocytes; Transfection; Tumor Cells, Cultured; Wortmannin | 1995 |
[Multiple cutaneous neoplasms in cyclosporine therapy after kidney transplantation].
Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysplastic Nevus Syndrome; Follow-Up Studies; Humans; Immune Tolerance; Kidney Transplantation; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Precancerous Conditions; Skin Neoplasms | 1995 |
Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukemia; Lymphoma; Male; Melanoma; Neoplasms; Risk Factors; Skin Neoplasms; Time Factors | 1995 |
Hamster Greene melanoma in the rabbit eye: immunosuppressive treatment to improve this tumor model.
Topics: Animals; Anterior Chamber; Cricetinae; Cyclosporine; Disease Models, Animal; Eye Neoplasms; Female; Immune Tolerance; Immunization; Melanoma; Necrosis; Neoplasm Transplantation; Rabbits | 1994 |
Establishment of pigmented choroidal melanomas in a rabbit model.
Topics: Animals; Choroid Neoplasms; Cyclosporine; Disease Models, Animal; Fundus Oculi; Humans; Immunosuppression Therapy; Melanoma; Neoplasm Transplantation; Rabbits; Tumor Cells, Cultured | 1994 |
Heterotransplantation of human uveal melanoma.
Topics: Aged; Aged, 80 and over; Animals; Choroid Neoplasms; Cyclosporine; Disease Models, Animal; Eye Enucleation; Female; Fundus Oculi; Graft Rejection; Humans; Immunosuppression Therapy; Melanoma; Neoplasm Transplantation; Rabbits; Transplantation, Heterologous; Tumor Cells, Cultured; Ultrasonography | 1993 |
Excess benign melanocytic naevi in renal transplant recipients.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Back; Buttocks; Case-Control Studies; Cyclosporine; Follow-Up Studies; Foot Diseases; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Melanoma; Middle Aged; Nevus, Pigmented; Prednisone; Prevalence; Risk Factors; Skin Neoplasms; Time Factors; Transplantation, Homologous | 1997 |
Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Compartmentation; Cells, Cultured; Cyclosporine; DNA-Binding Proteins; Doxorubicin; Fluorescent Antibody Technique, Indirect; Gene Expression; Golgi Apparatus; Humans; Melanoma; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; Probenecid; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1998 |
Induction of mitochondrial permeability transition and cytochrome C release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Caspase Inhibitors; Caspases; Cyclosporine; Cytochrome c Group; Cytosol; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fluorescence; HL-60 Cells; Humans; Intracellular Membranes; Melanoma; Mitochondria; Mitochondria, Liver; Neoplasm Proteins; Oligopeptides; Permeability; Photochemistry; Pyrimidinones; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Signal Transduction; Skin Neoplasms; Staurosporine; Tumor Cells, Cultured | 2000 |
Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma.
Topics: Animals; Biopsy; Cell Culture Techniques; Choroid Neoplasms; Cyclosporine; Female; Humans; Immunosuppressive Agents; Melanoma; Neoplasm Transplantation; Rabbits; Transplantation, Heterologous; Tumor Cells, Cultured; Uveal Neoplasms | 2000 |
Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis.
Topics: Apoptosis; Bongkrekic Acid; Burkitt Lymphoma; Calcium Signaling; Caspase 9; Caspases; Cyclosporine; Cytochrome c Group; Depsipeptides; DNA Fragmentation; Enzyme Activation; HL-60 Cells; Humans; Intracellular Membranes; Ion Channels; Melanoma; Membrane Potentials; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptides, Cyclic; Permeability; Thapsigargin; Tumor Cells, Cultured | 2001 |